Diuretics versus Angiotensin-Converting Enzyme Inhibitors in Autosomal Dominant Polycystic Kidney Disease

Publisher： Karger

E-ISSN： 1421-9670|21|2|98-103

ISSN： 0250-8095

Source： American Journal of Nephrology, Vol.21, Iss.2, 2001-05, pp. : 98-103

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

No Effect of Angiotensin-Converting Enzyme Gene Polymorphism on Disease Progression and Left Ventricular Hypertrophy in Autosomal Dominant Polycystic Kidney Disease

By  

American Journal of Nephrology, Vol. 23, Iss. 6, 2003-11 ,pp. : 466-470

Karger

Access to resources Recommend Favorite

Effects of the Angiotensin II Receptor Antagonist Candesartan Cilexetil on Blood Pressure and Proteinuria in Patients with Autosomal Dominant Polycystic Kidney Disease

By  

Nephron, Vol. 86, Iss. 3, 2000-11 ,pp. : 385-386

Karger

Access to resources Recommend Favorite

Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?

By  

Nephron, Vol. 133, Iss. 3, 2016-06 ,pp. : 147-158

Karger

Access to resources Recommend Favorite

Dimensions of Arteriovenous Fistulas in Patients with Autosomal Dominant Polycystic Kidney Disease

By  

Nephron, Vol. 85, Iss. 1, 2000-04 ,pp. : 50-53

Karger

Access to resources Recommend Favorite

Autosomal Dominant Polycystic Kidney Disease – Clinical and Genetic Aspects

By  

Kidney and Blood Pressure Research, Vol. 25, Iss. 5, 2002-11 ,pp. : 265-283

Karger

Access to resources Recommend Favorite